OPK

1.31

0.00% 0.00

Handel nachbörslich: 1.33 0.02 +1.53%

Opko Health Inc (OPK)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt OPK? Forum Prognose

Schlusskurs vom Vortag:

$1.31

Offen:

$1.32

24-Stunden-Volumen:

3.71M

Relative Volume:

1.17

Marktkapitalisierung:

$989.17M

Einnahmen:

$581.12M

Nettoeinkommen (Verlust:

$-212.92M

KGV:

-4.7845

EPS:

-0.2738

Netto-Cashflow:

$-174.22M

1W Leistung:

-20.61%

1M Leistung:

-13.82%

6M Leistung:

+4.80%

1J Leistung:

+3.15%

1-Tages-Spanne:

$1.28

$1.345

1-Wochen-Bereich:

$1.28

$1.65

52-Wochen-Spanne:

$0.9769

$1.73

Opko Health Inc Stock (OPK) Company Profile

Firmenname

Opko Health Inc

Sektor

Healthcare (1080)

Branche

Diagnostics & Research (49)

Telefon

305-575-4181

Adresse

4400 BISCAYNE BLVD., MIAMI, FL

Mitarbeiter

2,275

Twitter

Nächster Verdiensttermin

2026-07-27

Neueste SEC-Einreichungen

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, IDXX, NTRA, A

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OPK Opko Health Inc	1.31	936.31M	581.12M	-212.92M	-174.22M	-0.2738
TMO Thermo Fisher Scientific Inc	564.75	207.93B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	194.78	138.14B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	588.09	43.87B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	275.19	36.95B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	139.20	38.94B	7.23B	1.41B	1.09B	4.979

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-20	Eingeleitet	JP Morgan	Neutral
2025-10-31	Herabstufung	Jefferies	Buy → Hold
2025-04-25	Eingeleitet	JP Morgan	Neutral
2023-06-29	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-12-15	Eingeleitet	H.C. Wainwright	Buy
2022-01-24	Herabstufung	Barrington Research	Outperform → Mkt Perform
2021-06-21	Eingeleitet	Ladenburg Thalmann	Buy
2019-11-25	Eingeleitet	Piper Jaffray	Overweight
2018-03-02	Herabstufung	JP Morgan	Neutral → Underweight
2017-09-14	Herabstufung	JP Morgan	Overweight → Neutral
2016-06-21	Bestätigt	Standpoint Research	Buy
2016-06-03	Eingeleitet	Standpoint Research	Buy
2016-03-31	Bestätigt	Barrington Research	Outperform
2015-10-16	Eingeleitet	JP Morgan	Overweight
2015-09-11	Herabstufung	Jefferies	Buy → Hold
2015-03-03	Herabstufung	Oppenheimer	Outperform → Perform
2014-05-12	Bestätigt	Oppenheimer	Outperform
2014-03-14	Eingeleitet	Oppenheimer	Outperform
2013-11-13	Bestätigt	Ladenburg Thalmann	Buy
2013-05-30	Bestätigt	Ladenburg Thalmann	Buy
2012-10-22	Eingeleitet	Barrington Research	Outperform
2011-12-01	Bestätigt	Ladenburg Thalmann	Buy
2011-07-14	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Opko Health Inc Aktie (OPK) Neueste Nachrichten

Jul 28, 2026

Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results - Benzinga

Jul 28, 2026

OPKO Health (NASDAQ:OPK) Shares Gap Up Following Strong Earnings - MarketBeat

Jul 28, 2026

Why Is OPKO Health (NASDAQ:OPK) Stock Drawing Fresh Market Interest Today? - Kalkine Media

Jul 28, 2026

OPK Looks 19.0% Overvalued on GF Value™ - GuruFocus

Jul 28, 2026

Jul 27, 2026

OPKO Health, Inc. 2026 Q2 10-Q Report: Financial Statements, Risk Factors, and Management Discussion - Minichart

Jul 27, 2026

OPK Looks 17.9% Overvalued on GF Value™ - GuruFocus

Jul 27, 2026

OPKO Health Q2 2026 Results: Key Pipeline Advances, Rayaldee China Expansion, and Improved Financial Performance – Minichart - Minichart

Jul 27, 2026

OPKO Health (NASDAQ:OPK) Shares Rise After Q2 Earnings Exceed Forecasts; Nicoya Agreement Lifts After-Hours Gains - TechStock²

Jul 27, 2026

Earnings call transcript: OPKO Health posts smaller Q2 loss, shares rise in 2026 - Investing.com Canada

Jul 27, 2026

OPK: Q2 2026 delivered higher revenue, improved margins, and raised full-year guidance amid pipeline advances - TradingView

Jul 27, 2026

OPKO Health Q2 Earnings Call Highlights - MarketBeat

Jul 27, 2026

Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Jul 27, 2026

OPK: Profitability improved and revenue grew in Q2 2026, with guidance raised for the full year - TradingView

Jul 27, 2026

OPKO Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 27, 2026

OPKO Health Q2 EPS beats estimates as sales rise 4.3% to $163.5 million - scanx.trade

Jul 27, 2026

OPKO Health (NASDAQ:OPK) Issues Earnings Results - MarketBeat

Jul 27, 2026

OPKO HEALTH ($OPK) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative

Jul 27, 2026

OPKO HEALTH, INC. Q2 2026: Revenue $163.6M, EPS $(0.01) — 10-Q Summary - TradingView

Jul 27, 2026

OPKO Health: Q2 Earnings Snapshot - Yahoo Finance

Jul 27, 2026

(OPK) OPKO Health, Inc. Expects Q3 Revenue Range $131.0M$142.0M - marketscreener.com

Jul 27, 2026

OPKO Health reports Q2 2026 revenue $163.5M, operating loss narrows to $7.0M, net loss $8.4M - TradingView

Jul 27, 2026

OPKO Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Jul 27, 2026

OPK: Q2 2026 revenue rose and losses narrowed, with clinical and partnership progress highlighted - TradingView

Jul 27, 2026

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results - OPKO Health, Inc.

Jul 27, 2026

OPKO Begins Phase 1 Trials in B-Cell Lymphoma, COVID Prevention - Stock Titan

Jul 27, 2026